Skip to content

Cardiac Dimensions

Cardiac Dimensions is a privately held medical device company headquartered in Kirkland, Washington, developing the Carillon Mitral Contour System for functional mitral regurgitation in heart failure patients.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Cardiac Dimensions is a privately held company headquartered in Kirkland, Washington, with operations in the United States, Australia, and Germany. Its mission is to bring more success to the treatment of heart failure patients, and it has developed the Carillon Mitral Contour System, described as a completely different and much earlier approach to treating functional mitral regurgitation (FMR) than other device therapies. The Carillon therapy is a short, minimally invasive percutaneous procedure, usually about an hour, and is designed to work with the natural structure and function of the heart. A U.S. EMPOWER Clinical Trial is now enrolling for heart failure patients with large ventricles and functional mitral regurgitation.

History

Cardiac Dimensions is a privately held company headquartered in Kirkland, Washington, with operations in the United States, Australia, and Germany. The company states its mission is to bring more success to the treatment of heart failure patients. It has developed the Carillon Mitral Contour System, which it describes as a completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The Carillon therapy is a short, minimally invasive percutaneous procedure, usually about an hour, and is designed to work with the natural structure and function of the heart. A U.S. EMPOWER Clinical Trial is now enrolling for heart failure patients with large ventricles and functional mitral regurgitation. The company reports that in several published European studies, the majority of patients experienced an improvement in quality of life, mitral regurgitation, and LV volume.

Products and positioning

A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients; treating the condition—not just the symptoms.

  • Carillon Mitral Contour System

    A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients; a short, minimally invasive percutaneous procedure, usually about an hour, designed to work with the natural structure and function of the heart.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/cardiac-dimensions-united-states · Editorial policy · How profiles are compiled